Singapore REITs Monthly – February 2020 February 11, 2020 1084

  • FTSE S-REIT Index gained +4.0% MTD and +4.1% YTD. Strongest gains were from the healthcare sub-sector (+6.1%) and weakest showing at the hospitality sub-sector (-3.5%).
  • Performance in August: Best performer – Ascendas REIT (+10.4%), Worst performer – Far East Hospitality Trust (-10.0%).
  • Sector yield spread of 248bps over the benchmark 10-year SGS (10YSGS) yield was at the -1.5 standard deviation (SD) level.
  • 3M SOR inched up 10bps MoM, to end at 1.62%, which was 36bps lower YoY Remain NEUTRAL on S-REITs sector. Sub-sector preferences: Office and Industrial.

 

SECTOR SNAPSHOT

S-REIT yield and yield spread were 418bps and 248bps (-1.5 SD level) respectively. The lower yields were driven by the 105pts YoY increase in the FTSE S-REIT Index which ended at 943pts. The 10YRSGS was 4 bps lower MoM while the 3M SOR inched up 10bps MoM, to end at 1.62%, which was 36bps lower YoY.

Hospitality (-4.1% MoM) S-REITs were sold down in light of the Novel Coronavirus outbreak as investors fled to Industrial REITs (+4.5% MoM).

Fresh into 2020, SREITs sector saw the proposed merger of CapitaLand Mall Trust (CMT) and CapitaLand Commercial Trust (CCT) which if approved by shareholders, will result in the new CapitaLand Integrated Commercial Trust (CICT) which will have a market capitalisation of S$16.8bn and AUM of S$22.9bn.

Elite Commercial REIT debuted on the SGX on 6th February with a portfolio of 97 commercial building across the UK. 99% of gross rental income (GRI) is derived from leases to the UK government’s Department of Work and Pensions. Elite listed with a Forecast Year 2020 dividend yield of 7.1% and was 3.2x and 8.3x subscribed by the institutional and retail tranches respectively. The appraised value of the IPO portfolio is GBP319mn (S$571mn).

Singapore remains an attractive market for REITs listings with several IPOs lined up. Hampshire US REIT will be lodging their prospectus in February 2020 with a portfolio of 18 grocery and self-storage assets worth US$882mn (S$785mn).

 

Outlook

Office – Office occupancy was flat QoQ but improved 1.6ppts YoY while the office rental index moderate in 2H19 after 16 consecutive quarters of growth. Positive rental reversions are still expected for the office sector which typically follows a 3-year leasing cycle (Figure 5) as passing rents are currently below market rents.

Industrial – Industrial rents have been bottoming out over the past 16 quarters while occupancy remained stable at 89.3%. Of the 4.4% of supply coming onto the market in FY20, 70% of supply will be coming from the light industrial segments and will put pressure on rents and occupancy. However, 50% of the light industrial supply are build-to-suit assets and are pre-committed.

Retail – Despite a weak retail sector outlook with the RSI EX. MV in the red for the most of 2019 and considerable retail supply coming onto the market (Funan, Jewel, Paya Lebar Quarter), the retail index climbed 2.9% with industry occupancy improving a 100bps YoY to 92.5%. 70,000sqm of supply coming onto the market in 2020 and 2021, representing a 1.2% increase in retail stock. Most of the retail supply hitting the market are part of mixed-use developments with <10,000sqft of retail space, hence indirectly competing against suburban malls in those locations.

Hospitality – Low supply of rooms hitting the market over the next 3 years bodes positively for the SG hospitality sector. Room supply is expect to grow by 1.1%/1.0% in FY20/FY21. The muted supply in 2019 saw RevPAR improving 9.1% on the back of higher room rates and occupancy, which improved 3.6% and 45bps YoY. However, the evolving Novel Coronavirus epidemic will thwart the supply tailwinds.

Important Information

This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.

By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.

The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.

Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.

This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.

Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.

Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.

Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.

To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.

The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.

This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.

This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.

IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE

Where the report contains research analyses or reports from a foreign research house, please note:

  1. recipients of the analyses or reports are to contact Phillip Securities Research (and not the relevant foreign research house) in Singapore at 250 North Bridge Road, #06-00 Raffles City Tower, Singapore 179101, telephone number +65 6533 6001, in respect of any matters arising from, or in connection with, the analyses or reports; and
  2. to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore who is not an accredited investor, expert investor or institutional investor, Phillip Securities Research accepts legal responsibility for the contents of the analyses or reports.
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Get access to all the latest market news, reports, technical analysis
by signing up for a free account today!